What The Market Refuses To Pay For FSLR
A solar giant is growing like a startup, yet its stock is priced as if the sun is about to set. What does the market see that the numbers don’t?
After climbing 34% over the past year, shares of solar panel manufacturer First Solar (FSLR) trade around $227.72, yet still sit about 28% below their 52-week high. Here lies a paradox. The company’s revenue grew 27% over the last twelve months, but its stock offers a 6.8% earnings yield, a return that handily beats the 4.5% risk-free rate from a 10-year Treasury. Growth like that rarely comes so cheaply. This raises a critical question for investors: Is the market correctly anticipating a sharp reversal, or is it overlooking sustained growth at a bargain price?
Are these earnings even real?
At a trailing P/E of 14.7x, an investor is effectively paying a price that implies the company’s current earnings will pay back the investment in under 15 years, even with zero future growth. The market appears to be valuing First Solar’s recent 27% expansion at nothing. This isn’t an accounting fiction, either. The company’s operating cash flow is a healthy 147% of its net income, confirming the profits are backed by cash. Nor is this a one-off recovery; the three-year average revenue growth is a consistent 25%.
The business momentum appears solid on the surface. Management reported a “record first quarter revenue” and recently secured bookings for 1.4 gigawatts in its “key U.S. utility-scale market” at strong prices. The company is also rolling out its next-generation CuRe panel technology, which it believes could add up to $0.6 billion in revenue from existing contracts through 2028.
Why would the market ignore this performance?
The market is not ignoring the numbers; it is questioning their durability. The core of the skeptical case is a business risk, not a financial metric. First Solar’s competitive strength in the U.S. hinges on favorable trade policies that shield it from lower-priced Chinese competitors. This advantage is not guaranteed to last. The company’s international operations already show signs of strain, with facilities in Malaysia and Vietnam running at “significantly reduced utilization” due to weaker pricing and demand.
The market fears this weakness could spread to the U.S. if trade policy shifts. A key tariff ruling, the “pending 232 polysilicon derivatives tariff decision,” looms over the industry. The uncertainty is palpable, with management noting that some customers with orders for “multiple gigawatts of volume” are waiting for a decision before committing. For investors who believe in the solar theme but are wary of this single-company risk, a broader solar or semiconductor ETF like FXN might offer an alternative path.
Will a single tariff decision validate the price?
Nearly the entire debate over First Solar’s valuation comes down to this regulatory outcome. In response to the uncertainty, management is taking a “highly selective approach to incremental U.S. bookings” until it has more clarity. The company’s future pricing power, and by extension its earnings, is directly tied to the government’s next move.
Management stated on its recent earnings call that it expects a decision on the Section 232 tariffs in the second quarter. A favorable ruling could unlock the pent-up demand and reaffirm the premium pricing that supports its current earnings. An unfavorable one would validate the market’s deep skepticism. That decision is the test that will determine whether First Solar’s stock is a bargain or a value trap.
Hunting for more growth the market has not paid up for? Our Guidance Momentum screen tracks every S&P 500 name where a rising forecast is meeting real price momentum.
One Mispricing Is A Trade. A System Is A Portfolio
Finding growth the market refuses to pay for is exactly the kind of edge worth hunting. But an anomaly on one stock can stay unresolved for years, or resolve against you, and a single name carries the full weight of that wait.
The Trefis High Quality (HQ) Portfolio applies the same discipline across the whole market: about 30 businesses selected on quality itself, consistent cash generation, strong margins, resilient balance sheets, then sized and re-balanced with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Chase the anomalies you find convincing, on top of a core that does not need any single one to pay off.